Early Research Links GLP-1 Drugs To Fertility Benefits In Men And Women

18 Jun 20264 min read0 viewsVerified Feed

GIST (Key Takeaways)

Fertility is closely linked to metabolic health , with obesity being a significant factor that can negatively affect reproductive function in both males and females . Having overweight or obesity can contribute to hormonal imbalances , insulin resistance , chronic inflammation , and altered reproductive hormone signaling, all of which may impair fertility.
In females, obesity is often associated with conditions such as polyendocrine metabolic ovarian syndrome (PMOS) , formerly knows as PCOS, while in males, it can reduce testosterone levels and adversely affect sperm quality . Thus, lifestyle changes , such as adopting balanced dietary plans, engaging in regular physical activity, and maintaining a healthy weight, can help enhance reproductive outcomes and support fertility.
GLP-1 receptor agonists , such as Wegovy , which contain the active ingredient semaglutide , are a class of medications widely used for obesity and type 2 diabetes . Now, emerging research suggests these medications may also have positive effects on reproductive health.
Two studies indicate that GLP-1 drugs may offer reproductive benefits, in addition to supporting weight loss and metabolic health.

Medical News Today published a clinical update in Research Highlights on 18 Jun 2026.

The item focuses on GLP-1 drugs show early promise for improving fertility in males and females.

Review the original article for the full source wording and details.

Read the full original publication from the source journal or publisher link below.

Feed Metadata

Source

Medical News Today